And the year guidance is 34-39 . 8.5x4 = 34 - other Qs are expected exceed or be as good as Q1.
Let's put it this way - from now on all quarters are going to beat the record of Q2 2012.
As I understand, they gave out guidance for Q1 mostly because the the order from Q4 rolled into this one and is already counted.
on its face eman missed number expected by piper low 9.1 million but management stated 2+ million pushed into q-1, new depo fixed, guidnce raised for the year, and we got a first down , and still have the ball or in better terms "we are growing, tuning our new depo to meet demand"
short term we missed the number long term we are invested in a growth story!